Deborah Miller, Ph.D., J.D., currently serves as the Chief Legal Officer and Secretary at NUVALENT INC CLASS A, a position she has held with distinction. With a robust background in both science and law, Dr. Miller brings a unique blend of expertise to her role. She earned her Ph.D. in Biochemistry from Stanford University, where her research focused on the molecular mechanisms of cancer, laying a strong foundation for her future work in the biopharmaceutical industry. Following her scientific pursuits, she attended Harvard Law School, where she obtained her J.D., further enhancing her capabilities and preparing her for a career at the intersection of science and legal practice. Before joining NUVALENT INC CLASS A, Dr. Miller held several key positions that honed her skills and broadened her experience. She worked as a patent attorney at a leading intellectual property law firm, where she specialized in biotechnology and pharmaceuticals, helping clients protect their innovations and navigate complex regulatory environments. Additionally, she served as General Counsel at a mid-sized biopharma company, where she played a pivotal role in guiding the company through its IPO and subsequent growth phases. Her strategic legal insights and deep understanding of the scientific underpinnings of the industry have made her an invaluable asset to NUVALENT INC CLASS A. In her current role as Chief Legal Officer and Secretary at NUVALENT INC CLASS A, Dr. Miller oversees all legal affairs of the company, including intellectual property management, corporate governance, and compliance with regulatory requirements. Her leadership is instrumental in steering the company towards its mission of developing innovative treatments for cancer. Dr. Miller's dual expertise in biochemistry and law allows her to provide comprehensive guidance that aligns the company's legal strategies with its scientific objectives, ensuring that NUVALENT INC CLASS A remains at the forefront of the biopharmaceutical industry.